Interestingly, HDAC6 inhibition inhibited tumor cell proliferation, and when knocked down cells were inoculated in animal models a decreased PD-L1 production and an augmented T-cell-mediated immune response was obtained [138]. Here, HDAC6 is linked to neoplasm.